Citigroup’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14M | Sell |
429,284
-191,795
| -31% | -$6.24M | 0.01% | 863 |
|
|
2025
Q1 | $23.5M | Buy |
621,079
+241,871
| +64% | +$9.13M | 0.01% | 637 |
|
|
2024
Q4 | $31M | Buy |
379,208
+158,665
| +72% | +$13M | 0.02% | 497 |
|
|
2024
Q3 | $25.2M | Buy |
220,543
+54,748
| +33% | +$6.26M | 0.01% | 582 |
|
|
2024
Q2 | $12.5M | Buy |
165,795
+20,928
| +14% | +$1.58M | 0.01% | 804 |
|
|
2024
Q1 | $9.9M | Buy |
144,867
+65,955
| +84% | +$4.51M | 0.01% | 896 |
|
|
2023
Q4 | $4.96M | Sell |
78,912
-16,527
| -17% | -$1.04M | ﹤0.01% | 1137 |
|
|
2023
Q3 | $4.87M | Buy |
95,439
+16,816
| +21% | +$857K | ﹤0.01% | 1048 |
|
|
2023
Q2 | $3.93M | Sell |
78,623
-69,463
| -47% | -$3.47M | ﹤0.01% | 1231 |
|
|
2023
Q1 | $5.55M | Buy |
148,086
+29,320
| +25% | +$1.1M | ﹤0.01% | 1077 |
|
|
2022
Q4 | $5.69M | Sell |
118,766
-36,673
| -24% | -$1.76M | ﹤0.01% | 1013 |
|
|
2022
Q3 | $3.73M | Buy |
155,439
+99,373
| +177% | +$2.38M | ﹤0.01% | 1248 |
|
|
2022
Q2 | $1.22M | Buy |
56,066
+43,686
| +353% | +$951K | ﹤0.01% | 1930 |
|
|
2022
Q1 | $299K | Sell |
12,380
-34,053
| -73% | -$822K | ﹤0.01% | 3172 |
|
|
2021
Q4 | $1.11M | Buy |
46,433
+21,159
| +84% | +$504K | ﹤0.01% | 2443 |
|
|
2021
Q3 | $641K | Sell |
25,274
-59,741
| -70% | -$1.52M | ﹤0.01% | 2729 |
|
|
2021
Q2 | $1.91M | Sell |
85,015
-28,311
| -25% | -$637K | ﹤0.01% | 2128 |
|
|
2021
Q1 | $2.24M | Buy |
113,326
+108,056
| +2,050% | +$2.13M | ﹤0.01% | 1864 |
|
|
2020
Q4 | $140K | Buy |
5,270
+4,396
| +503% | +$117K | ﹤0.01% | 3449 |
|
|
2020
Q3 | $43K | Buy |
+874
| New | +$43K | ﹤0.01% | 3564 |
|